triamcinolone acetonide has been researched along with Uveal Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Böker, A; Davids, AM; Hager, A; Joussen, AM; Riechardt, AI; Seibel, I | 1 |
| Alegret, AM; Cebulla, CM; Feuer, WJ; Murray, TG; Schefler, AC; Shi, W | 1 |
| El Filali, M; Homminga, I; Jager, MJ; Maat, W; van der Velden, PA | 1 |
| Horgan, N; Mashayekhi, A; Materin, MA; O'Regan, M; Salazar, PF; Shields, CL; Shields, JA | 1 |
| Bianciotto, CG; Materin, MA; Shields, CL; Wu, C | 1 |
| Dario, A; Midena, E; Miglionico, G; Parrozzani, R; Pilotto, E | 1 |
1 trial(s) available for triamcinolone acetonide and Uveal Neoplasms
| Article | Year |
|---|---|
Periocular triamcinolone for prevention of macular edema after plaque radiotherapy of uveal melanoma: a randomized controlled trial.
Topics: Brachytherapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Injections; Iodine Radioisotopes; Macular Edema; Male; Melanoma; Middle Aged; Prospective Studies; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveal Neoplasms; Visual Acuity | 2009 |
5 other study(ies) available for triamcinolone acetonide and Uveal Neoplasms
| Article | Year |
|---|---|
Antiangiogenic or Corticosteroid Treatment in Patients With Radiation Maculopathy After Proton Beam Therapy for Uveal Melanoma.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Implants; Female; Fovea Centralis; Glucocorticoids; Humans; Intravitreal Injections; Macula Lutea; Macular Edema; Male; Melanoma; Middle Aged; Proton Therapy; Radiation Injuries; Retinal Diseases; Retrospective Studies; Triamcinolone Acetonide; Uveal Neoplasms; Visual Acuity | 2016 |
Tumor volume reduction using combined phacoemulsification and intravitreal triamcinolone injection for the management of cataract with treated uveal melanoma and atypical nevi.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Combined Modality Therapy; Female; Glucocorticoids; Humans; Injections; Male; Melanoma; Middle Aged; Nevus, Pigmented; Phacoemulsification; Postoperative Complications; Retrospective Studies; Triamcinolone Acetonide; Tumor Burden; Ultrasonography; Uveal Neoplasms; Visual Acuity; Vitreous Body | 2008 |
Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth.
Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Eye Proteins; Humans; Melanoma; Nerve Growth Factors; Pregnadienediols; Serpins; Thrombospondin 1; Triamcinolone Acetonide; Uveal Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
Sector laser photocoagulation for the prevention of macular edema after plaque radiotherapy for uveal melanoma: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Brachytherapy; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Laser Coagulation; Macula Lutea; Macular Edema; Male; Melanoma; Middle Aged; Pilot Projects; Radiation Injuries; Radiotherapy Dosage; Tomography, Optical Coherence; Triamcinolone Acetonide; Uveal Neoplasms | 2012 |
Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Brachytherapy; Exudates and Transudates; Female; Follow-Up Studies; Glucocorticoids; Humans; Intravitreal Injections; Iodine Radioisotopes; Male; Melanoma; Middle Aged; Refraction, Ocular; Retinal Detachment; Retrospective Studies; Subretinal Fluid; Treatment Outcome; Triamcinolone Acetonide; Ultrasonography; Uveal Neoplasms; Vascular Endothelial Growth Factor A; Visual Acuity | 2013 |